Liver Injury REMS Delays US FDA Approval Of Agios’s Pyrukynd In Thalassemia

 
• By Mandy Jackson
  
Analysts expect Pyrukynd to receive FDA approval to treat thalassemia despite the action date delay. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Drug Safety

More from United States